In addition to the three factors identified here, there are many other potential sources of cellular ROS – such as inflammation, mitochondrial DNA mutations, or metabolic adaptations [95] – which might all be contributory to the ALT phenotype in different tumours. The gene discussed is GPT; the disease is neoplasm.